196 related articles for article (PubMed ID: 12396740)
1. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
Clement S; Still JG; Kosutic G; McAllister RG
Diabetes Technol Ther; 2002; 4(4):459-66. PubMed ID: 12396740
[TBL] [Abstract][Full Text] [Related]
2. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
Kipnes M; Dandona P; Tripathy D; Still JG; Kosutic G
Diabetes Care; 2003 Feb; 26(2):421-6. PubMed ID: 12547873
[TBL] [Abstract][Full Text] [Related]
3. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial.
Clement S; Dandona P; Still JG; Kosutic G
Metabolism; 2004 Jan; 53(1):54-8. PubMed ID: 14681842
[TBL] [Abstract][Full Text] [Related]
4. Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects.
Wajcberg E; Miyazaki Y; Triplitt C; Cersosimo E; DeFronzo RA
Diabetes Care; 2004 Dec; 27(12):2868-73. PubMed ID: 15562199
[TBL] [Abstract][Full Text] [Related]
5. Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.
DiCostanzo CA; Moore MC; Lautz M; Scott M; Farmer B; Everett CA; Still JG; Higgins A; Cherrington AD
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E46-52. PubMed ID: 15713685
[TBL] [Abstract][Full Text] [Related]
6. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.
Hamann A; Matthaei S; Rosak C; Silvestre L;
Diabetes Care; 2003 Jun; 26(6):1738-44. PubMed ID: 12766103
[TBL] [Abstract][Full Text] [Related]
8. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
9. Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.
Launay B; Zinman B; Tildesley HD; Strack T; Chiasson JL
Diabetes Care; 1998 Oct; 21(10):1627-31. PubMed ID: 9773721
[TBL] [Abstract][Full Text] [Related]
10. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
[TBL] [Abstract][Full Text] [Related]
11. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
Clin Ther; 2004 May; 26(5):724-36. PubMed ID: 15220016
[TBL] [Abstract][Full Text] [Related]
12. Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.
Sargin H; Sargin M; Altuntaş Y; Sengül AM; Orbay E; Seber S; Uçak S; Yayla A
Diabetes Res Clin Pract; 2003 Nov; 62(2):79-86. PubMed ID: 14581144
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes.
Guevara-Aguirre J; Guevara-Aguirre M; Saavedra J; Bernstein G; Rosenbloom AL
Diabetes Technol Ther; 2007 Aug; 9(4):372-6. PubMed ID: 17705693
[TBL] [Abstract][Full Text] [Related]
14. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
Rosenstock J; Park G; Zimmerman J;
Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
[TBL] [Abstract][Full Text] [Related]
15. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
16. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
Fulcher GR; Gilbert RE; Yue DK
Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
[TBL] [Abstract][Full Text] [Related]
17. Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).
Gribble FM; Manley SE; Levy JC
Diabetes Care; 2001 Jul; 24(7):1221-5. PubMed ID: 11423506
[TBL] [Abstract][Full Text] [Related]
18. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.
DeWitt DE; Dugdale DC
JAMA; 2003 May; 289(17):2265-9. PubMed ID: 12734138
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
Becker RH; Frick AD; Nosek L; Heinemann L; Rave K
Diabetes Care; 2007 Oct; 30(10):2506-7. PubMed ID: 17675541
[No Abstract] [Full Text] [Related]
20. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]